CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus YÖKSİS DOI Eşleşti SJR Q2

How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?

Internal Medicine Journal · Ekim 2018

Özet
Background: Procalcitonin (PCT) and C-reactive protein (CRP) are used most widely in the diagnosis/treatment of bacterial infections. These are not infection-specific and may also show increases in other inflammation-causing cases. Aim: To establish a new cut-off value for PCT and CRP to eliminate confusion in the diagnosis and treatment of bacterial infections in haemodialysis (HD) patients. Methods: A total of 1110 patients, 802 with undocumented infection and 308 with documented infection, was included in the study. Results: A total of 802 patients with undocumented infection had a mean CRP value of 12.2 ± 9.6 mg/dL and a mean PCT value of 0.51 ± 0.96 ng/mL and the 308 patients with documented infection had a mean CRP value of 125.9 ± 83.3 mg/dL and a mean PCT value of 13.9 ± 26.9 ng/mL at the time of admittance. In HD patients, the cut-off values for CRP was determined as 19.15 mg/dL and for PCT as 0.685 ng/mL in the presence of infection. The use of these two parameters in combination (CRP ≥19.15 mg/dL and PCT ≥ 0.685 ng/mL) was found to have 95% positive predictive value (PPV) and 93% negative predictive value (NPV) for the diagnosis of infectious diseases in HD patients. When CRP ≥100 mg/dL and PCT ≥5 ng/mL, this was found to have 100% PPV and 94% NPV for the diagnosis of sepsis in HD patients. Conclusion: We specified PCT and CRP cut-off values with high PPV and NPV for revealing the presence of bacterial infection and sepsis in HD patients.
15 atıf Ekim 2018 DOI
YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
INTERNAL MEDICINE JOURNAL · 2018 SCI
Prof. Dr. ONUR URAL →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?.
INTERNAL MEDICINE · 2018 SCI
Prof. Dr. ŞUA SÜMER →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
Internal Medicine Journal · 2018 SCI
Prof. Dr. ONUR URAL →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
INTERNAL MEDICINE JOURNAL · 2018 SCI
Prof. Dr. NAZLIM AKTUĞ DEMİR →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
INTERNAL MEDICINE JOURNAL · 2018 SCI
Prof. Dr. GÜLPERİ ÇELİK →
YÖKSİS Kayıtları — ISSN Eşleşmesi
Bu dergide (ISSN eşleşmesi) kurumun 2 kaydı bulundu.
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
2018 ISSN: 1444-0903 SCI
Prof. Dr. ONUR URAL →
How should procalcitonin and C-reactive protein levels be interpreted in haemodialysis patients?
2018 ISSN: 1444-0903 SCI
Prof. Dr. ONUR URAL →

Makale Bilgileri

Toplam Atıf 15 atıf · Scopus
ISSN14440903
Yayın TarihiEkim 2018
Cilt / Sayfa48 · 1222-1228

Kurumlar

Necmettin Erbakan Üniversitesi
Meram Turkey
Selçuk Tip Fakültesi
Konya Turkey
Süleyman Demirel University, Faculty of Medicine
Isparta Turkey

Havuzumuzdaki Atıflar 0

Bu makaleye, sistemimizdeki Scopus veritabanında bulunan 0 makale atıf yapmıştır. Scopus genel atıf sayısı: 15.

Bu makaleye, kendi Scopus havuzumuzdaki başka bir makaleden atıf kaydı bulunmuyor.
Scimago Dergi (ISSN Eşleşmesi)
Internal Medicine Journal
Q2
SJR Skoru0,537
H-Index88
YayıncıJohn Wiley and Sons Inc
ÜlkeUnited States
Internal Medicine (Q2)
Dergi sayfasına git

Metrikler

15
Atıf

Sistemimizdeki Yazarlar